|Domain:||Professional Services & Consulting|
|Contact:||Ch. Du Champ des filles 19
1228 Plan-les-Ouates / GE
Find an actor
9th International Conference on Structural Biology18.09.2017Structural Biology 2017 gladly welcomes all the participants from all over the world to join the upcoming prestigious...
Welcome To Health ValleyBuilding on skills honed over the centuries, western Switzerland has become a world leader in biotech.
Tolerys SATherapeutics & Diagnostics, Other
Tolerys SA is an early stage biotech company developing a novel anti-inflammatory immunotherapy named EFD BCG. This product is derived from BCG vaccine using a patented inactivation process.
Therapeutics & Diagnostics, Vaccines
Preclinical studies proved that EFD BCG relies on its unique capacity to induce regulatory T cells in several models of chronic inflammatory diseases and is associated with a favorable safety profile.
In parallel to preclinical R&D, Tolerys SA has developed EFD BCG's manufacturing process and is preparing a first-in-man clinical trial.